Latham & Watkins LLP is pleased to announce that 34 associates have been elected to the partnership and another 48 associates have been promoted to the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised KoBold on the round. KoBold Metals has announced a $195 million funding round, bringing the company’s valuation to over $1 billion and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented WellTheory in the transaction. WellTheory has announced its US$7.2 million seed funding round led by Accel, with participation from Box Group, Lux Capital,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced that it secured US$150...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Standard Metrics in the transaction. Standard Metrics, the data and relationships platform for the private capital markets formerly known as Quaestor, has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Kobold Metals in the transaction. Kobold Metals, an AI powered mineral exploration company, has announced it has raised US$192.5 million in its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented OpenSea in the transaction. OpeanSea, an NFT marketplace, raised US$300 million in its Series C financing resulting in a US$13.3 billion post...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Mineralys Therapeutics, Inc. in the transaction. Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific, completed a US$40...
You must be a Standard 1 Year member to access this content.
